Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration, and the ...

Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year. The DNA testing company has faced major ...

Choose The Business Journals as a preferred news source to see more of our reporting on Google.

The genetic testing company's new Palo Alto office represents a dramatic reduction from the 155,000 square feet it once ...

Biotech company 23andMe was once hailed as one of the most successful businesses selling DNA analysis services to anybody who could afford one of its saliva test kits. But 18 years after it was ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

Andy Page, former president of digital health startups 23andMe and Livongo, joined Caption Health as CEO earlier this year, the San Francisco-based artificial intelligence company announced Oct. 1.

The sale of the bankrupt DNA data bank 23andMe is facing delays as the company tries to find a lead bidder that can quickly clear regulatory hurdles and guarantee customer privacy rules will be ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Maven, a digital health startup providing access to virtual fertility, pregnancy and postpartum services, announced on Feb. 19 the close of a $45 million Series C round that included participation ...

Here's what to know if you are a 23andMe user, or if you've uploaded raw DNA data from 23andMe to other websites.